Last reviewed · How we verify
NCT04068129
Enhanced Housing Photoscreeners 2WIN and GoCheckKids Compared in Burma and Alaska
trial testing photoscreen in Amblyopia in 162 participants. Completed in 15 April 2019.
12 April 2019
Quick facts
| Lead sponsor | Alaska Blind Child Discovery |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 162 |
| Start date | 11 February 2019 |
| Primary completion | 12 April 2019 |
| Estimated completion | 15 April 2019 |
| Sites | 1 location across United States |
Drugs / interventions tested
- photoscreen
Conditions studied
- Amblyopia — all drugs for Amblyopia →
- Anisometropia — all drugs for Anisometropia →
Sponsor
Alaska Blind Child Discovery
Who can join
Adults 6 Months to 40, any sex, with Amblyopia or Anisometropia. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
"Adaptica" (Padova, Italy) designed a fixed-distance, dark portable tube with power and remote control for the "2WIN: photoscreener. GoChecksKids designed a flash-concentrating case for the iPhone 7+ to more quickly achieve two-axis photoscreen. These devices were compared to confirmatory exams in children and young adults in a remote Burma clinic and in an Alaskan pediatric ophthalmology practice.
Publications & conference data
1 peer-reviewed publication reference this trial (live from Europe PMC):
-
Performance of Two Photoscreeners Enhanced by Protective Cases.
Martin SJ, Htoo HE, Hser N, Arnold RW. · · 2020 · cited 16× · PMID 32546951 · DOI 10.2147/opth.s251451
Verify or expand the search:
- PubMed search for NCT04068129
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Amblyopia
Currently open trials in the same condition.
- NCT07323953 — Evaluation of AmblyoFix for the Treatment of Unilateral Amblyopia in Children · NA · recruiting
- NCT07281742 — Amblyopia Treatment for Children Aged 8 to 12 Years · NA · recruiting
- NCT07417046 — Possible Beneficial Effects Of Combined Fluoxetine And Occlusion Therapy In Improving And Maintaining Vision In Amblyopi · NA · recruiting
- NCT06524882 — Dichoptic Treatment for Amblyopia in Children 8 to 12 Years of Age · Phase 3 · recruiting
- NCT06380517 — Dichoptic Treatment for Amblyopia in Children 4 to 7 Years of Age · Phase 3 · recruiting
Other Alaska Blind Child Discovery trials
Trials by the same sponsor.
- NCT06165705 — Treating Amblyopia With CureSight · NA · unknown
- NCT04249505 — Refractive Accuracy of "2WIN" and Portable Autorefractors · completed
- NCT04195711 — Comparative Validation of "Blinq" and "2WIN" Vision Screeners · completed
- NCT04297969 — Hyperopia Detection GCK With Glow Fixation · completed
- NCT03668067 — Performance of 2WIN Photoscreener With Corneal Reflex Compared to School Bus Retinoscopy by AAPOS Guidelines · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04068129 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Alaska Blind Child Discovery
- Last refreshed: 19 October 2020
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04068129.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing